From Data to Decisions: Leveraging Artificial Intelligence and Machine Learning in Combating Antimicrobial Resistance – a Comprehensive Review.

The emergence of drug-resistant bacteria poses a significant challenge to modern medicine. In response, Artificial Intelligence (AI) and Machine Learning (ML) algorithms have emerged as powerful tools for combating antimicrobial resistance (AMR). This review aims to explore the role of AI/ML in AMR...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Medical Systems Vol. 48; no. 1; pp. 1 - 15
Autores principales: de la Lastra, José M. Pérez, Wardell, Samuel J. T., Pal, Tarun, de la Fuente-Nunez, Cesar, Pletzer, Daniel
Formato: pictorial review tables/charts Journal Article
Publicado: Springer Nature 8/1/2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=179604833&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 179604833
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01485598
        4N0
      jtl: Journal of Medical Systems
      issn: 01485598
      maglogo: N
    pubinfo:
      dt: 8/1/2024
      vid: 48
      iid: 1
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        179604833
        179604833
        179604833
        10.1007/s10916-024-02089-5
        179604833
      ppf: 1
      ppct: 14
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: From Data to Decisions: Leveraging Artificial Intelligence and Machine Learning in Combating Antimicrobial Resistance – a Comprehensive Review.
      aug:
        au:
          de la Lastra, José M. Pérez
          Wardell, Samuel J. T.
          Pal, Tarun
          de la Fuente-Nunez, Cesar
          Pletzer, Daniel
        affil: https://ror.org/028ev2d94 Biotechnology of Macromolecules, Instituto de Productos Naturales y Agrobiología, IPNA (CSIC), Avda. Astrofísico Francisco Sánchez, 3, 38206, San Cristóbal de la Laguna, (Santa Cruz de Tenerife), Spain
      sug:
        subj:
          Drug Resistance, Microbial Evaluation
          Artificial Intelligence
          Machine Learning
          Algorithms
          Data Management
          Decision Making, Clinical
          Infection Microbiology
          Infection Drug Therapy
          Antibiotics Therapeutic Use
          Microbial Culture and Sensitivity Tests
          Treatment Outcomes
          Drug Discovery
          Drug Administration
          Infection Diagnosis
          Severity of Illness Evaluation
          Data Quality
          Infection Pathology
          Antimicrobial Stewardship
          Individualized Medicine
          Antibiotics Administration and Dosage
          Antimicrobial Peptides
      ab: The emergence of drug-resistant bacteria poses a significant challenge to modern medicine. In response, Artificial Intelligence (AI) and Machine Learning (ML) algorithms have emerged as powerful tools for combating antimicrobial resistance (AMR). This review aims to explore the role of AI/ML in AMR management, with a focus on identifying pathogens, understanding resistance patterns, predicting treatment outcomes, and discovering new antibiotic agents. Recent advancements in AI/ML have enabled the efficient analysis of large datasets, facilitating the reliable prediction of AMR trends and treatment responses with minimal human intervention. ML algorithms can analyze genomic data to identify genetic markers associated with antibiotic resistance, enabling the development of targeted treatment strategies. Additionally, AI/ML techniques show promise in optimizing drug administration and developing alternatives to traditional antibiotics. By analyzing patient data and clinical outcomes, these technologies can assist healthcare providers in diagnosing infections, evaluating their severity, and selecting appropriate antimicrobial therapies. While integration of AI/ML in clinical settings is still in its infancy, advancements in data quality and algorithm development suggest that widespread clinical adoption is forthcoming. In conclusion, AI/ML holds significant promise for improving AMR management and treatment outcome.
      pubtype: Academic Journal
      doctype:
        pictorial
        review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N